A specific metabolic regulator identified in cancers is a potential drug target with a proto-drug in development.

“And one of those switches — basically jumped out of this analysis as like the top you know differentiator if you will — that expressed in Cancers and not — and others Now it's a it's you know it's the type of molecule that historically has been thought to be challenging to create a drug against — there actually is a proto-drug against it that's you know so pre-clinical but you know moving forward we've been collaborating academically with that company and — and so early days in terms of knowing whether this is really going to you know kind of bear out”